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Many African countries, through their development plans, have ƉƌŝŽƌŝƟƐĞĚĂĐĐĞƐƐƚŽĂīŽƌĚĂďůĞ
healthcare services. However, the 
ƌĞĂůŝƐĂƟŽŶŽĨƚŚĞƐĞĂƐƉŝƌĂƟŽŶƐŚĂƐ
ďĞĞŶĐŽŶƐƚƌĂŝŶĞĚĚƵĞƚŽƚŚĞŚŝŐŚĐŽƐƚƐ




is important since up to 90% of the 
ƉŽƉƵůĂƟŽŶďƵǇƐŵĞĚŝĐŝŶĞƐƚŚƌŽƵŐŚŽƵƚͲ
ŽĨͲƉŽĐŬĞƚƉĂǇŵĞŶƚƐ͘
As a result, many African countries 
ŚĂǀĞƐƚĂƌƚĞĚŝŶŝƟĂƟǀĞƐƚŽƉƌŽŵŽƚĞ
ůŽĐĂůƉŚĂƌŵĂĐĞƵƟĐĂůŵĂŶƵĨĂĐƚƵƌŝŶŐ͕
to address the issue of high costs 
























and other related issues, a study was 





transfer and covered nine ECOWAS 
ĐŽƵŶƚƌŝĞƐͲ'ŚĂŶĂ͕EŝŐĞƌŝĂ͕^ĞŶĞŐĂů͕
ƀƚĞĚ͛/ǀŽŝƌĞ͕dŽŐŽ͕ĞŶŝŶ͕DĂůŝ͕'ƵŝŶĞĂ
This policy brief arises from a study 
commissioned by the Scinnovent 




















to address the human resource 
requirements for the sector in West 
ĨƌŝĐĂ͘
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BUILDING A COMPETITIVE AND SOCIALLY INCLUSIVE LOCAL 
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Strategies for enhancing affordability through procurement and related policy 
incentives for the Sector
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ŽŶĂŬƌǇĂŶĚĂƉĞsĞƌĚĞ͘dŚĞƐĞ
ĐŽƵŶƚƌŝĞƐǁĞƌĞƐĞůĞĐƚĞĚďĂƐĞĚŽŶ












of medicine and therefore enhance 
ĂĐĐĞƐƐĂŶĚĂīŽƌĚĂďŝůŝƚǇĂŶĚƐŽĐŝĂů
inclusion. 
The study achieved the following: 













from those countries that have 
implemented such policies. 






























1. There exists procurement policy 
/ŶĐĞŶƟǀĞƐ
dŚĞƐƚƵĚǇĞƐƚĂďůŝƐŚĞĚƚŚĂƚ͕ŵŽƐƚ









• WƌĞĨĞƌĞŶƟĂůƚƌĞĂƚŵĞŶƚ: All the 










































• Ring-fencing of certain products: 
All the countries have recently 
ĂƉƉůŝĞĚƚŚĞƉŽůŝĐǇŽĨƌŝŶŐͲ





products to restrict them to only 




















formula and dosage as those 










is, in principle, free of duty and 
ŝŵƉŽƌƚƚĂǆĞƐ͘dĂƌŝīƉƌĞĨĞƌĞŶĐĞƐ
for processed products require 
two prior approvals (of the 
ƉƌŽĚƵĐƚĂŶĚƚŚĞŵĂŶƵĨĂĐƚƵƌĞƌͿŝŶ
ĂĚĚŝƟŽŶƚŽƚŚĞĐĞƌƟĮĐĂƚĞŽĨŽƌŝŐŝŶ




all the countries have put in 
ƉůĂĐĞŶĂƟŽŶĂůŚĞĂůƚŚŝŶƐƵƌĂŶĐĞ
ƐĐŚĞŵĞƐ͕ǁŚŝĐŚĐĂŶďĞĂŶ










As a result, following the 
ŝŶƚƌŽĚƵĐƟŽŶŽĨĂƉŽůŝĐǇƚŚĂƚ












and the informal sector through 
community health. (Source: 
Ministerial circular MSAS Sept 
ϮϬϭϵͿ͘
Ϯ͘dŚĞ/ŵƉĂĐƚŽĨƚŚĞƉƌĞĨĞƌĞŶƟĂů








• >ŽǁŽŵƉĞƟƟǀĞŶĞƐƐ͗ Local 
manufacturers in the nine 
ĐŽƵŶƚƌŝĞƐĂƌĞŶŽƚĂďůĞƚŽƚĂŬĞ
advantage of the procurement 
ƉƌĞĨĞƌĞŶƟĂůƉŽůŝĐŝĞƐĚƵĞƚŽůĂĐŬ
ŽĨĐŽŵƉĞƟƟǀĞŶĞƐƐŽĨƚŚĞůŽĐĂůůǇ
produced products compared to 
imported drugs. 
dŚŝƐŝƐĂƩƌŝďƵƚĞĚƚŽƚŚƌĞĞƌĞĂƐŽŶƐ͗
First: the cost of energy and water 
ŝƐƐŝŐŶŝĮĐĂŶƚůǇŚŝŐŚĞƌŝŶKt^
ƚŚĂŶŝŶ/ŶĚŝĂĂŶĚŚŝŶĂ͕ƚŚĞŵĂŝŶ
sources of imported medicines.
Second:ĂůůƉŚĂƌŵĂĐĞƵƟĐĂů
industries in the region import 
over 80% of their inputs, mainly 
ĨƌŽŵƚŚĞƚǁŽĐŽŵƉĞƟƚŽƌ
ĐŽƵŶƚƌŝĞƐ;/ŶĚŝĂĂŶĚŚŝŶĂͿ͘







materials, and excipients are 
imported.
Third:ĚƵĞƚŽƚŚĞůŽŶŐĚƵƌĂƟŽŶ
for imports of inputs, local 
industries are forced to hold large 





• WƌŽĚƵĐƟŽŶĂƉĂĐŝƚǇ͗ Local 
industries have not adequately 
ďĞŶĞĮƩĞĚĨƌŽŵƚŚĞŶĂƟŽŶĂů
ƚĞŶĚĞƌƉƌŽŐƌĂŵŵĞŽĨƌŝŶŐͲ
fencing products, since they do 
ŶŽƚŚĂǀĞŝŶƚŚĞŝƌƉŽƌƞŽůŝŽĂůůƚŚĞ
ϲϬƌĞƋƵĞƐƚĞĚƉƌŽĚƵĐƚƐǁŚŝĐŚ
is a generalised principle in the 
region. 




increased the prices of the drugs 
























level and excludes regional and 
ĨĂĐŝůŝƚǇůĞǀĞůƐǁŚŝĐŚĐŽŶƐƟƚƵƚĞ
ĂůŵŽƐƚϱϬйŽĨƚŚĞƚŽƚĂůƉƵďůŝĐ
medicine procurement. Therefore, 
local manufacturers lose out 
at the regional and facility 
procurement levels where the 
margin of preference is not 
ĐŽŶƐŝĚĞƌĞĚƐŝŶĐĞƚŚĞǇĂƌĞŽŌĞŶ
ŶŽƚǀĞƌǇĐŽŵƉĞƟƟǀĞǁŚĞƌĞ
the margin of preference is not 













formulas or rules or statements 
ƵƉƚŽϱϲйŽŶŝŵƉŽƌƚƚĂƌŝīƐ͘
ƌĂǌŝůĂƉƉůŝĞƐϭϱйŽŶĨŽƌŵƵůĂƐ






has introduced measures to 
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ĞŶƐƵƌĞƚŚĂƚϳϬйŽĨƚŚĞƉƌŽĚƵĐƚƐ
ƉƵƌĐŚĂƐĞĚďǇƚŚĞƐƚĂƚĞĂƌĞ









mainly through a policy of 
ƉƌŽŚŝďŝƟŽŶŽĨŝŵƉŽƌƚĂƟŽŶ
ŽĨŵĞĚŝĐŝŶĞƐƚŚĂƚĐŽƵůĚďĞ



















procurement requires that the 
ƉƌŽĚƵĐƚŵƵƐƚďĞt,KƉƌĞƋƵĂůŝĮĞĚ͘
KƵƚŽĨŵŽƌĞƚŚĂŶϭϳϮŵĂŶƵĨĂĐƚƵƌŝŶŐ










































procurement of medicines for Malaria, 
d͕,/sͬ/^͕ĂŶĚƌĞƉƌŽĚƵĐƟǀĞŚĞĂůƚŚ͘
However, local companies have not 
ƉĂƌƟĐŝƉĂƚĞĚŝŶƚŚĞƉƌŽĐƵƌĞŵĞŶƚ
processes for these medicines 






roadmap programme had progressed 
as planned most of the companies 
ǁĞƌĞĞǆƉĞĐƚĞĚƚŽďĞt,K'DW
ĐŽŵƉůŝĂŶƚǁŝƚŚŝŶĮǀĞǇĞĂƌƐďǇϮϬϮϬ͘























individualised improvement program 




The following conclusions and 
ƌĞĐŽŵŵĞŶĚĂƟŽŶƐǁĞƌĞŵĂĚĞĨƌŽŵ
ƚŚĞĮǀĞŵĂŝŶĮŶĚŝŶŐƐŽĨƚŚĞƐƚƵĚǇ͗
a. All the nine countries reviewed have 
ŝŶƉůĂĐĞƉƌŽĐƵƌĞŵĞŶƚƉŽůŝĐǇŝŶĐĞŶƟǀĞƐ
ƚŽƐƵƉƉŽƌƚůŽĐĂůƉŚĂƌŵĂĐĞƵƟĐĂů











and dosage as those manufactured 
ůŽĐĂůůǇ͘ dŚĞƐĞŝŶƚĞƌǀĞŶƟŽŶƐďǇ
Kt^ĐŽƵŶƚƌŝĞƐĂƌĞůĂƵĚĂďůĞ






















and the limited capacity of the local 
industries. 
dŽŝŵƉƌŽǀĞŽŶĐŽŵƉĞƟƟǀĞŶĞƐƐŝŶ


















to revisit the cost of local inputs, 
ƉĂƌƟĐƵůĂƌůǇĞŶĞƌŐǇĂŶĚǁĂƚĞƌĂŶĚ



































content policy in Senegal.
d. Three lessons learned from 
ĞůƐĞǁŚĞƌĞĂƌĞǁŽƌƚŚĐŽŶƐŝĚĞƌŝŶŐďǇ




















industries, donor support on provision 
ŽĨŵĞĚŝĐŝŶĞƐŝƐĂŬĞǇĨĂĐƚŽƌŝŶ
enhancing access to healthcare and 
ĂīŽƌĚĂďŝůŝƚǇĂŶĚĐĂŶƚŚĞƌĞĨŽƌĞŶŽƚďĞ












that can partner with local industries. 
dŚĞƌĞĨŽƌĞ͕ĚĞůŝďĞƌĂƚĞĞīŽƌƚƐďǇƚŚĞ
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